Zoom’s AI Mirage: Record Profit Hides a Shrinking Core

In Short

Zoom's record profit is a mirage—$1.61B Anthropic gain masks a core business growing just 4.9%. Stock fell 7% as AI hype fails to deliver real revenue. Is the AI-first story over? Read the full breakdown.

The Lede and the Real Story

Zoom Communications reported what looks like a blowout quarter: Q2 FY2027 revenue of $1.28 billion, up 4.9% year over year, and GAAP net income of $1.54 billion—a staggering figure that management touted as ‘record profitability.’ But the stock fell 7% in after-hours trading, and for good reason. The headline profit is almost entirely a paper gain from an investment in Anthropic, not from operations. Strip out that $1.61 billion windfall, and Zoom’s core business is barely growing—enterprise revenue rose 7.8%, its best in three years, but total revenue growth actually decelerated from 5.5% in Q1 to 4.9% in Q2. The company raised full-year guidance, but only by a hair, and the market’s reaction suggests investors see through the spin.

The real story is that Zoom is a mature, low-growth company trying to rebrand itself as an AI powerhouse. Management leans heavily on buzzwords like ‘AI-first system of action’ and ‘digital twins,’ but the numbers tell a different tale: online revenue, the consumer and small-business segment, continues to decline, and the enterprise growth is still modest for a company with Zoom’s valuation. The stock’s drop is a signal that the market is no longer buying the narrative.

Inside the Full Analysis

  • 🔒The Negative Space — What They Didn’t Say
  • 🔒Script vs. Reality
  • 🔒Evasion Tactics & The Hot Seat
  • 🔒Excuses vs. Execution
  • 🔒The CAN SLIM Check
  • 🔒Conclusion


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading